Skip to content

David R. Roalf

2 papers in the library · 15 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Cannabis use and glutamate across the psychosis spectrum: in vivo evidence from 7T proton magnetic resonance spectroscopy

Molecular Psychiatry June 27, 2026 David R. Roalf, Tyler M Moore, Jacquelyn Stifelman et al.

Abstract Cannabis use is linked to elevated psychosis risk, yet the neurobiological mechanisms that couple use to symptom expression remain unclear. Because glutamatergic dysregulation has been implicated in both cannabis effects and psychosis vulnerability, we examined whether brain glutamate relates to dimensional symptoms as a function of cannabis use across the psychosis spectrum....

DOI: 10.1038/s41380-026-03705-1 (opens in new tab) Full text (opens in new tab) Glutamatergic Psychosis Glutamate receptor Effects of cannabis +5

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.

Neuroscience & Biobehavioral Reviews November 1, 2023 Sophia Linguiti, Jacob W Vogel, Valerie J Sydnor et al. 15 citations

Functional magnetic resonance imaging (fMRI) is increasingly used to non-invasively study the acute impact of psychedelics on the human brain. While fMRI is a promising tool for measuring brain function in response to psychedelics, it also has known methodological challenges. We conducted a systematic review of fMRI studies examining acute responses to experimentally administered psychedelics...